Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C002202 |
4-oxoretinoic acid |
4-oxoretinoic acid results in increased expression of TGFB1I1 mRNA | increases expression | 15982314
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of TGFB1I1 mRNA | affects expression | 17562736
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of TGFB1I1 protein | affects expression | 20106945
|
C103303 |
alitretinoin |
alitretinoin results in increased expression of TGFB1I1 mRNA | increases expression | 15982314
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of TGFB1I1 mRNA | affects expression | 16483693
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite affects the expression of TGFB1I1 mRNA | affects expression | 17331233
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of TGFB1I1 mRNA | increases expression | 20106945
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of TGFB1I1 mRNA | increases expression | 15336504
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of TGFB1I1 mRNA | increases expression | 20106945
|
C004742 |
daidzein |
daidzein promotes the reaction [TGFB1I1 protein results in increased activity of AR protein] | increases activity|increases reaction | 17252558
|
C014347 |
decitabine |
decitabine results in increased expression of TGFB1I1 mRNA | increases expression | 19194470
|
D004041 |
Dietary Fats |
Dietary Fats results in increased expression of TGFB1I1 mRNA | increases expression | 18042831
|
D004317 |
Doxorubicin |
TGFB1I1 protein affects the susceptibility to Doxorubicin | affects response to substance | 16217747
|
D005419 |
Flavonoids |
Flavonoids results in decreased expression of TGFB1I1 mRNA | decreases expression | 18035473
|
C041786 |
palm oil |
palm oil results in increased expression of TGFB1I1 mRNA | increases expression | 18042831
|
D010656 |
Phenylephrine |
Phenylephrine results in increased expression of TGFB1I1 protein | increases expression | 19540241
|
D010656 |
Phenylephrine |
[Phenylephrine results in increased phosphorylation of MAPK1 protein] which affects the expression of TGFB1I1 protein | affects expression|increases phosphorylation | 19540241
|
D010656 |
Phenylephrine |
[Phenylephrine results in increased phosphorylation of MAPK3 protein] which affects the expression of TGFB1I1 protein | affects expression|increases phosphorylation | 19540241
|
D010656 |
Phenylephrine |
TGFB1I1 protein promotes the reaction [Phenylephrine results in increased expression of ACTA1 mRNA] | increases expression|increases reaction | 19540241
|
D010656 |
Phenylephrine |
TGFB1I1 protein promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA] | increases expression|increases reaction | 19540241
|
D010656 |
Phenylephrine |
TGFB1I1 protein promotes the reaction [Phenylephrine results in increased expression of NPPA protein] | increases expression|increases reaction | 19540241
|
D015474 |
Isotretinoin |
Isotretinoin results in increased expression of TGFB1I1 mRNA | increases expression | 15982314
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of TGFB1I1 mRNA | increases expression | 20106945
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of TGFB1I1 mRNA | decreases expression | 19465110
|
D014212 |
Tretinoin |
Tretinoin metabolite results in increased expression of TGFB1I1 mRNA | increases expression | 15982314
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of TGFB1I1 mRNA | increases expression | 15982314
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of TGFB1I1 mRNA | increases expression | 16604517
|
D014415 |
Tunicamycin |
Tunicamycin results in increased expression of TGFB1I1 mRNA | increases expression | 17127020
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Isotretinoin |
8.41 | 18769834 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.41 | 11752688 14514962 15322242 |
MESH:D000015 |
Abnormalities, Multiple |
|
Isotretinoin |
4.90 | 18769834 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.47 | 18287403 |
MESH:D017486 |
Acneiform Eruptions |
|
Isotretinoin |
6.20 | 16232082 |
MESH:D000152 |
Acne Vulgaris |
|
Isotretinoin |
5.40 | 16185265 18769834 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
7.15 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
daidzein |
7.15 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
7.15 | 17418594 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.60 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.29 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.46 | 21441931 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.54 | 15955085 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.87 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.76 | 10982225 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.99 | 19183758 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Phenylephrine |
4.03 | 17460149 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
3.80 | 15238619 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.02 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.24 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.32 | 16456186 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.43 | 18445737 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.32 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.66 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
8.66 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.71 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.71 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.62 | 14601052 |
MESH:D001919 |
Bradycardia |
|
Phenylephrine |
4.46 | 15306635 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.73 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
alitretinoin |
3.72 | 16344269 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
3.72 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
3.72 | 19208741 18320071 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
3.72 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
3.72 | 15994142 15136595 18382427 16935488 11325840 16264153 17983394 17426702 17369602 15567936 15668708 15939500 16595493 18695136 16826403 16096432 15692762 18234424 18628466 19526202 15993339 16322301 15634643 16115903 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
3.72 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
3.72 | 16166294 16443354 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.50 | 16813970 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.73 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.73 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.08 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
6.47 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
6.47 | 12907637 21507988 12619106 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
6.47 | 16234567 17876044 18059187 16023760 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
6.47 | 1917145 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.12 | 16201981 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
14.09 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
14.09 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
14.09 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Isotretinoin |
14.09 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
14.09 | 16051514 16096774 |
MESH:D006332 |
Cardiomegaly |
|
Phenylephrine |
6.72 | 11754973 16170337 15728586 11179087 17124262 17287366 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.72 | 16120746 18850075 18670907 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.47 | 17924179 16242529 16278810 16612575 16269455 17007740 17308081 17131338 18627295 16455267 17928571 16364871 17351982 17519947 16651473 17974986 17382496 15811867 16731534 15476868 15792986 16952015 15505089 16109756 17329180 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.92 | 16243910 17334414 |
MESH:D002318 |
Cardiovascular Diseases |
|
daidzein |
4.19 | 16332659 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
7.05 | 10977129 |
MESH:D002386 |
Cataract |
|
Tretinoin |
7.05 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.47 | 12371664 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.50 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.08 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
2.85 | 19486331 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.08 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.64 | 12621046 16354765 15668235 8697196 15340226 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.64 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.62 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.32 | 17616700 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.67 | 18981723 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.67 | 18802399 18259882 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.98 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Isotretinoin |
3.85 | 18769834 9879862 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.85 | 20055451 15322242 10048152 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
3.85 | 9142499 17551590 16925845 8800419 10589399 14991402 9664655 9125849 9211117 9224671 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
daidzein |
4.60 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.60 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
6.03 | 10774834 17522070 11834606 11421492 16227642 12153990 15619225 11743745 2444490 12540782 12392966 14725611 19085960 16781746 14986274 11529661 16081117 19739265 19420014 18713872 19923254 11739529 16177239 10663392 19164858 15968718 12594235 12958197 16485898 17906064 19370779 12705907 16393943 11287661 17562736 19416960 16109766 18071297 11461765 14550746 10915739 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
6.03 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.03 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.02 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
7.89 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.89 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.39 | 18367378 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.30 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
11.67 | 18230668 16714409 15322242 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
11.67 | 18230668 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.03 | 19294695 |
MESH:D016889 |
Endometrial Neoplasms |
|
daidzein |
12.33 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
12.33 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
12.33 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.94 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.08 | 18037988 |
MESH:D007172 |
Erectile Dysfunction |
|
daidzein |
4.93 | 14972507 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
1.99 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.61 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.61 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
7.46 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
7.46 | 17967931 19551842 19004024 18296743 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.37 | 11858732 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.50 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
20.43 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
20.43 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
20.43 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
20.43 | 17994277 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.59 | 16983495 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.13 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
7.05 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
7.05 | 17312396 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.51 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
12.65 | 19215824 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
12.65 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
12.65 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.08 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
10.82 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
10.82 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
10.82 | 9664655 14991402 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.42 | 16244372 17888722 16495754 16707910 18006777 14766674 16879835 16244371 17875725 16144979 18674790 16330681 12587719 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.29 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.82 | 15692506 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.34 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.25 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.81 | 12621046 15340226 16120746 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.33 | 18501091 17606976 15147373 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.96 | 16959395 18606429 16354765 15340226 8697196 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
7.39 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
7.39 | 16870215 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.51 | 21332399 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.48 | 16778211 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.53 | 21332399 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
12.16 | 10903974 |
MESH:D006973 |
Hypertension |
|
daidzein |
12.16 | 17169123 |
MESH:D006973 |
Hypertension |
|
Phenylephrine |
12.16 | 12717712 8949925 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
12.16 | 18670907 18850075 |
MESH:D006984 |
Hypertrophy |
|
Phenylephrine |
4.47 | 18502941 12791704 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
3.14 | 17581917 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
8.05 | 20412841 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
8.05 | 17296493 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
8.05 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
3.05 | 18457598 11836018 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.68 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.66 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.66 | 15992940 17551590 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.36 | 15604871 |
MESH:D017492 |
Keratosis, Seborrheic |
|
alitretinoin |
5.55 | 16144296 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
9.74 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
9.74 | 18776723 8314463 10903974 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
9.74 | 15369732 16775033 15699352 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.07 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.66 | 12371664 |
MESH:D007938 |
Leukemia |
|
decitabine |
6.28 | 19235587 18980019 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
6.28 | 17143497 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.08 | 16085563 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
9.29 | 18454857 17236224 19117987 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
9.29 | 16482212 16932348 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
3.92 | 18460780 17679729 19010910 18704418 19387464 18206229 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
3.92 | 16294345 17596541 19850784 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.38 | 18055864 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.09 | 16331271 17712046 19225113 17506722 15748426 16788101 16766008 12679006 17368321 19642359 19035177 9834237 17217047 16891316 16140955 17301526 16935935 19029980 17339181 17294898 16823087 17649720 19075265 17361223 17107899 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.24 | 9224671 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
2.83 | 18296743 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
3.45 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.45 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
3.45 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.61 | 19460945 12969438 16610002 16611625 19784758 12587719 19014921 11587558 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.16 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
7.19 | 18177683 15890375 2125692 9163691 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
7.19 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.19 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
9.54 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
9.54 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
9.54 | 12151625 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
3.94 | 17365036 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
8.43 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
alitretinoin |
8.43 | 16413115 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
8.43 | 20064080 6695378 20869020 20464547 18569708 17053015 18816296 20135361 18520028 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
8.43 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Isotretinoin |
8.43 | 15899809 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
8.43 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
decitabine |
7.51 | 19470736 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
7.51 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.72 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.48 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
2.97 | 15458769 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.75 | 17453147 |
MESH:D008545 |
Melanoma |
|
decitabine |
7.25 | 16505122 17785578 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
7.25 | 16827129 |
MESH:D008545 |
Melanoma |
|
Isotretinoin |
7.25 | 17237267 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
7.25 | 16752155 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.48 | 19513568 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.34 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
6.32 | 18303189 16166281 16966607 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
6.32 | 17638057 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.71 | 16801185 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.42 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.12 | 16381670 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.70 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
3.28 | 18172295 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
7.31 | 19010910 16882708 18608210 19157545 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
7.31 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
2.91 | 15857846 19429709 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.95 | 12213967 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
2.92 | 18259882 |
MESH:D009369 |
Neoplasms |
|
alitretinoin |
11.56 | 16946489 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
11.56 | 11141357 |
MESH:D009369 |
Neoplasms |
|
decitabine |
11.56 | 19116145 17925555 19470736 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
11.56 | 16594593 16946489 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.68 | 16636307 16899518 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.36 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
9.04 | 19348381 18481113 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
9.04 | 16889571 15640375 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.22 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
9.22 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
3.00 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
7.21 | 15555623 |
MESH:D009447 |
Neuroblastoma |
|
Isotretinoin |
7.21 | 17368321 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.80 | 18514411 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
2.27 | 19632207 18674790 20132043 21332399 17217161 18457598 16723640 11836018 20518802 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.04 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
4.87 | 19331143 19259094 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
4.87 | 16936753 |
MESH:D010146 |
Pain |
|
Acetaminophen |
6.34 | 16870215 |
MESH:D010146 |
Pain |
|
Tretinoin |
6.34 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
5.27 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
5.27 | 15976015 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.17 | 12520081 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.08 | 17983394 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
4.81 | 10923243 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.08 | 17638057 |
MESH:D017499 |
Porokeratosis |
|
alitretinoin |
5.92 | 16144296 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.47 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.14 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Isotretinoin |
9.56 | 18769834 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.56 | 11118676 11399792 11222880 11896295 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.64 | 17616702 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.31 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.31 | 16729912 16888761 15897917 18437689 16868541 15749863 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.52 | 16636307 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.20 | 16882103 |
MESH:D011596 |
Psychomotor Disorders |
|
Isotretinoin |
5.83 | 18769834 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.71 | 16723453 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
3.00 | 17975199 17322281 17365031 15814490 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.13 | 17922066 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.75 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
10.67 | 19155313 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
10.67 | 16116481 16283617 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.91 | 17710206 16767912 17203757 15625365 15675481 18313854 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.16 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.70 | 17846226 |
MESH:D012852 |
Sinusitis |
|
Phenylephrine |
4.62 | 7327846 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
17.48 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
17.48 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
17.48 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
17.48 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
17.48 | 16467112 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.48 | 16767912 15625365 17203757 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
3.33 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
3.33 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
3.33 | 17261132 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.82 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
11.67 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
11.67 | 17909728 16010429 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
11.67 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.71 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.17 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
8.19 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
8.19 | 17616700 19087683 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
8.19 | 17653716 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.89 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.60 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
12.56 | 17785578 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
12.56 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.90 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.51 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.13 | 17638931 17334414 17678736 16364871 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.97 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.17 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.66 | 16723640 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.89 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.36 | 17120751 |